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Background: Globally, prison inmates are a high-risk population for tuberculosis (TB), but the specific drivers of
disease and impact of mass screening interventions are poorly understood.
Methods: We performed a prospective cohort study to characterize the incidence and risk factors for tuberculosis
infection and disease in 12 Brazilian prisons, and to investigate the effect of mass screening on subsequent disease
risk. After recruiting a stratified random sample of inmates, we administered a questionnaire to ascertain symptoms
and potential risk factors for tuberculosis; performed tuberculin skin testing (TST); collected sera for HIV testing; and
obtained two sputum samples for smear microscopy and culture, from participants reporting a cough of any
duration. We repeated the questionnaire and all tests for inmates who remained incarcerated after 1 year. TST
conversion was defined as TST ≥10 mm and an induration increase of at least 6 mm in an individual with a
baseline TST <10 mm. Cox proportional hazard models were performed to identify risk factors associated with
active TB. To evaluate the impact of screening on subsequent risk of disease, we compared TB notifications over
one year among individuals randomized to screening for active TB with those not randomized to screening.
Results: Among 3,771 inmates recruited, 3,380 (89.6 %) were enrolled in the study, and 1,422 remained
incarcerated after one year. Among 1,350 inmates (94.9 %) with paired TSTs at baseline and one-year follow-up, 25.
7 % (272/1060) converted to positive. Among those incarcerated for the year, 10 (0.7 %) had TB at baseline and 25
(1.8 %) were diagnosed with TB over the subsequent year. Cases identified through active screening were less likely
to be smearpositive than passively detected cases (10.0 % vs 50.9 %; p < 0.01), suggesting early case detection.
However, there was no reduction in subsequent disease among individuals actively screened versus those not
screened (1.3 % vs 1.7 %; p = 0.88). Drug use during the year (AHR 3.22; 95 % CI 1.05–9.89) and knows somebody
with TB were (AHR 2.86; 95 % CI 1.01–8.10) associated with active TB during one year of follow up
Conclusions: Mass screening in twelve Brazilian prisons did not reduce risk of subsequent disease in twelve
Brazilian prisons, likely due to an extremely high force of infection. New approaches are needed to control TB in
this high-transmission setting.
Keywords: Tuberculosis, LTBI, Mass screening, Prisons, Case finding, Brazil, Cohort* Correspondence: juliocroda@gmail.com
†Equal contributors
1Faculty of Health Sciences, Federal University of Grande Dourados,
Dourados, Brazil
5Oswaldo Cruz Foundation, Campo Grande, Brazil
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Paião et al. BMC Infectious Diseases  (2016) 16:533 Page 2 of 8Background
Globally, incarcerated populations have among the highest
tuberculosis (TB) notification rates, frequently in excess of
20 times the rates of their corresponding non-incarcerated
communities [1]. Brazil has the world’s 4th largest prisoner
population, which grew by 86 % (335,410–622,202) be-
tween 2007 and 2015 (http://www.prisonstudies.org/high-
est-to-lowest/prison-population-total). While TB incidence
is declining in community settings across Brazil, it has
risen by nearly 40 % among incarcerated population over
the past seven years, representing 8 % of approximately
70,000 TB cases reported annually to the Ministry of
Health [2]. Moreover, a number of cross-sectional studies
have demonstrated a high prevalence of undiagnosed TB
among prisoners in Brazil [1, 3–6].
Prisons are optimal environments for TB transmission
since they bring together individuals with high rates of
tobacco, alcohol, and drug use, and limited access to
healthcare and TB diagnostics, into crowded, poorly ven-
tilated cells for 16–20 h a day [7, 8]. Determining which
interventions would be most effective and efficient in
reducing the burden of TB in such settings is difficult
due to the lack of data.
The World Health Organization (WHO) and Brazil’s
Ministry of Health recommend screening for active TB
upon initial entry into prisons and then annually. Yet, to
date Brazilian prisons have not implemented mass
screening recommendations since chest x-radiography
or laboratory facilities are not available. Cross-sectional
studies have demonstrated a high yield of annual screen-
ing for active TB among prisoners on a one-time basis,
but the yield of this approach over time and impact on
subsequent TB incidence remains uncertain [1, 3, 4].
In a previous model-based analysis, we projected a
modest reduction (8.3 %) in tuberculosis infection risk
following a 25 % reduction in time to TB diagnosis in 3
Brazilian prisons [7]. We hypothesized that the annual
mass screening with smear and culture could avert even
more transmission and thereby reduce TB incidence in
this setting. To address these questions, we designed a
prospective cohort study to evaluate the impact of an-
nual screening and assess TB infection and disease rates
in 12 Brazilian prisons.
Methods
Study location, population and study design
Brazil has a population of 200.4 million and 622,202 pris-
oners (incarceration rate of 311.1 per 100,000 population).
Mato Grosso do Sul state, located in Midwestern Brazil,
has a population of 2.5 million with 14,904 prisoners,
representing the highest national incarceration rate
(596.2 per 100,000 population) [9]. The penal system is
comprised of “closed” and “open” subsets to segregate
high and low-risk offenders (the latter of whom areallowed to leave the prison during daytime hours); 9,913
inmates in 22 penitentiaries comprise the total closed sub-
set. From January 2013 to December 2014, we conducted
a prospective cohort study in 8 male and 4 female prisons
in the cities of Campo Grande, Corumbá, Dourados,
Ponta Porã, and Três Lagoas. The study population, 7,221
inmates, represents 59 % of the total state inmate popula-
tion and 73 % of inmates in the closed subset. Of the 12
study prisons, 8 male prisons included 6,552 inmates and
4 female prisons included 669 inmates.
Prior to the study, none of these 12 selected prisons
implemented the entrance and annual mass TB screening
recommended by WHO [10], and all TB cases were de-
tected passively by inmates seeking medical consultation
based on their symptoms; clinicians used clinical assess-
ment, smear and culture to make diagnoses. We con-
ducted a prospective study of active tuberculosis screening
in the study prisons.
Sample size calculation
Prisoners who were 18 years of age and who consented
to participate were recruited for the study. Proportional
stratified sampling was performed by using each prison
as a unit of randomization, as reported previously [8].
Screening for tuberculosis (reported here) was per-
formed alongside parallel screening studies for HIV,
Hepatitis B, Hepatitis C, and syphilis. The sample size
was calculated based on the expected prevalence of HIV,
as this was the lowest prevalence condition for the over-
all study. We assumed 2 % prevalence of HIV with an
error of +/−1 %, power of 80 % and alpha-type error of
5 %. The study population is 7,221 prisoners, and the
sample size was 3,159 prisoners. We added 20 % more
individuals to account for anticipated loss due to refusal
to participate, for a total of 3,771 prisoners.
Study procedures
We administered a questionnaire and tuberculin skin test
(TST) (PPD RT23, Staten Serum Institute, Copenhagen)
to all patients, and performed sputum smear microscopy
and culture for all participants reporting cough. The vari-
ables obtained during the interview included age, sex,
marital status, educational attainment, drug use over the
last year, history of sexually transmitted infections (STIs),
smoking, tuberculosis, self-reported mental illness and
diabetes mellitus, knows someone with TB and previous
incarceration. The participant’s race/ethnicity (i.e., white,
black, indigenous, Asian or mixed) was self-reported.
We scored clinical symptoms and signs according to
WHO guidelines: cough lasting for more than two weeks
(2 points), expectoration (2 points), chest pain (1 point),
weight loss in the last three months (1 point), and a recent
loss of appetite (1 point). A score equal to or greater than 5
points indicate a high probability of active disease [10–12].
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second sputum sample was collected the following
morning. Serum samples of participants were initially
screened with a commercial enzyme linked immuno-
sorbent assay (ELISA) for detection of antibodies against
HIV-1 and HIV-2 (Murex HIV-1.2.0, DiaSorin, Italy). All
positive and indeterminate specimens were confirmed
by Western blot assay (Novopath HIV-I, Immunoblot,
BioRad) [8]. TST positivity was defined as an induration
of ≥10 mm (≥5 mm for HIV-infected individuals), and
TST conversion was defined as TST ≥10 mm and an in-
duration increase of at least 6 mm in an individual with
a baseline TST <10 mm [10]. In HIV-positive individuals,
TST conversion was defined as an induration increase
of at least 6 mm in an individual with a baseline TST
<5 mm. Brazilian Ministry of Health (MoH) recommends
IPT only for HIV-infected inmates with positive TST.
After one year, we returned and administered a second
questionnaire and TST, and again performed smear mi-
croscopy and culture for all participants reporting
cough. To calculate the yield of smear, individuals with
positive sputum smear and/or culture in the first and
second screening were included in the active screening
group. Additionally, we reviewed prison medical records
and the National Notifiable Disease database (Sistema de
Informação de Agravos de Notificação National, SINAN)
to identify TB cases occurring between the study initi-
ation and conclusion. TB cases identified during these
period were included in the passive screening group. All
questionnaires were entered twice into the Research
Electronic Data Capture database (REDCap, secure online
database). SAS version 9.2 (SAS Institute, Cary, NC, USA)
was used to analyze bivariable and multivariable models.
Analytic approach
Tuberculosis cases were considered “actively detected” if
they were detected by diagnostics performed during
mass screening, conducted at baseline and after one
year. Cases were considered “passively detected” if they
were detected by routine presentation for medical care
between the two mass screening rounds; there was no
overlap between the two forms of diagnosis. The “active
screening” group was the group of inmates enrolled in
the study who were actively screened at baseline and
one year follow up. Cumulative incidence of active TB
was calculated using all incident cases notified by
SINAN between the two screening periods divided by all
the prisoners who remained one year in the same prison
in the two groups. We used survival curves and log-rank
test to compare the cumulative incidences of active tu-
berculosis among the group who underwent annual
screening with the group of individuals who did not
undergo annual screening. Cox proportional hazards
models were used to estimate crude (CHR) and adjustedhazards ratios (AHR) for active TB. Variables were in-
cluded in the model if they reached a significance level
of p < 0.20 by log-rank test, which was then trimmed
using stepwise backward selection. Statistical significance
was determined at a p value of <0.05.
Ethical issues
All eligible participants provided written informed consent
prior to study participation. The study was approved by
the Research Ethics Committee at the Federal University
of Grande Dourados (Number 793,740). All LTBI in HIV-
positive individuals and active TB cases identified during
the screening underwent medical consultation after the
test results and were referred for free tuberculosis treat-
ment or preventive therapy.
Results
From 7,221 inmates in the 12 prisons, we enrolled 3,380
inmates for the study. The results of initial screening were
previously reported [8]. Among these, 1,422 remained
incarcerated in the same prison after 1 year (Fig. 1);
this subset comprises the prospective cohort in whom
TST conversions and TB incidence were assessed. The
majority of study participants were men (87 %) and mean
age was 33 years old (SD: ±10 years, range: 18–80 years).
Previous incarceration was reported among 61 % of
participants, and 45 % had less than 4 years of school-
ing. We identified 18 (1.3 %) inmates with positive HIV
serology. At baseline, 66 % reported at least 1 TB symp-
tom as defined by the WHO and 23 % had productive
cough (Table 1). Among 1,422 inmates followed for one
year, baseline latent and active TB prevalence were 21 %
(95 % CI: 19–24 %) and 0.7 % (95 % CI: 0.3–1.3 %), re-
spectively (Fig. 1).
A second TST was performed in 1,379 (97 %) inmates
who remained incarcerated at one year. Among 1,089
participants with a negative TST at baseline, 1060 had a
TST performed at one year, and 272 (25.7 %, 95 % CI
22.7–28.9 %) converted. TST conversion was higher in
male compared to female prisoners (28 % versus 10 %;
p < 0.01), while TB incidence was non-significantly
higher (1.39 % versus 0.53 %; p = 0.68) (Table 2). No
difference in TST conversion rates was observed when
comparing HIV-uninfected and HIV-infected prisoners
(26 % versus 25 %, p = 0.95).
During the first year of follow-up, active TB was diag-
nosed in 18 participants in the active screening group.
All tested negative for HIV at baseline and after 1 year.
All but 1 case occurred among male inmates, and 9
(36 %) occurred in just one prison, the maximum-security
prison in Campo Grande. Seven cases were diagnosed at
the time of the second survey (Table 2).
While cases identified through active screening were
much less likely to be smear positive than those identified
Fig. 1 Flow chart of the study enrollment and screening process for active and latent tuberculosis (TB)
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was no statistical difference in the subsequent cumulative
incidence of the group that was actively screened versus
those not screened (1.3 % vs 1.7 %; log-rank p value =
0.88) (Fig. 2). Drug susceptibility testing are done by con-
ventional broth-based culture methods using the MGIT
960 system and did not identify any case of multidrug-
resistant tuberculosis. Drug use during the year (AHR
3.22; 95 % CI 1.05–9.89) and knows somebody with TB
were (AHR 2.86; 95 % CI 1.01–8.10) associated with active
TB during one year of follow up (Table 1).
Discussion
The extraordinarily high incidence of TB infection (25.7 %)
and disease (1,275 per 100,000 inmates) indicate a critical
need to address TB transmission inside prisons. By compar-
ing TB prevalence with incidence, we estimate an average6-month duration of disease before diagnosis, death, or re-
lease; it is during this window that transmission occurs.
While this period may be longer due to underestimation of
prevalence, it nevertheless reflects a narrow window for
diagnosis, in comparison with community estimates of in-
fectious duration that are often twice as long [13].
The effective contact rate (annual risk of infection di-
vided by prevalence) during this period is extremely high
(>36/year), reflecting high rates of transmission and
could represents the confluence of several factors: 1)
overcrowding; 2) poorly ventilated environments; 3) limited
TB diagnostic infrastructure; and 4) an inmate population
with low prevalence of latent tuberculosis infection (LTBI)
upon initial incarceration, who are at higher risk for infec-
tion upon exposure [7, 8, 14–16].
WHO and the Brazilian Ministry of Health recom-
mend screening for TB in prions at entry and annually;
Table 1 Risk factors associated with incident cases of active tuberculosis (TB) among inmates from 12 Brazilian prisons during one
year of follow-up (N = 1,422)
Variables N (%) Active TB
Crude hazard ratio p-value Adjusted hazard ratio p-value
Age (mean ± SD) 32.6 ± 9.7 0.99 (0.95–1.04)a 0.821
Sex (Male) 1235 (86.8) 2.63 (0.35–19.73) 0.348
Race
White 463 (33.9) 1.0
Mixed 685 (50.2) 0.94 (0.30–2.98) 0.924
Black 170 (12.5) 3.30 (1.01–10.83) 0.048b
Indigenous 19 (1.4) -
Asian 28 (2.1) -
Reported any WHO TB symptom at baseline 934 (65.7) 2.63 (0.76–9.09) 0.126b
Reported productive cough at baseline 325 (22.9) 2.25 (0.87–5.80) 0.094b
Less than 4 year of schooling 772 (55.5) 1.63 (0.61–4.36) 0.323
Diabetes Mellitus 0 (0.0) - -
Current Smoker 730 (51.8) 2.47 (0.88–6.94) 0.085b
HIV positive 18 (1.3) - -
Drug use over the last year 739 (52.0) 3.91 (1.29–11.87) 0.016b 3.22 (1.05–9.89) 0.042
Previous incarceration 860 (60.8) 1.03 (0.40–2.66) 0.951
TST positive 290 (21.0) 1.74 (0.60–5.00) 0.306
Previous TB 92 (6.6) 3.01 (0.90–10.70) 0.074b
Knows someone with TB 607 (43.5) 3.45 (1.24–9.73) 0.018b 2.86 (1.01–8.10) 0.049
aPer 1-year increase
bVariables initially included in the multivariate model, which was trimmed through backward selection
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any of the study prisons. In this study, mass screening
appeared to identify patients early in the course of disease,
as reflected by lower smear positivity rates (10.0 % vs





Individuals enrolled at baseline 2,861
Individuals followed for 1 year 1,235
TST-negative subjects 905
TST converted subjects 256
TST conversion rate, %a 28 (25–32)
Incident cases reported between screenings 17
TB cases at 1st screening 10
TB cases at 2nd screening 7
TB incidence, %a,b 1.39 (0.81–
Abbreviations: TB tuberculosis; TST tuberculin skin test
aPercentage and 95 % confidence interval
bCases identified between screenings or at second screening as a proportion of indsmear positivity have been demonstrated in community
settings comparing active and passive case detection [17].
However, subsequent TB incidence among screened indi-
viduals was not significantly reduced. This may be a result












2.22) 0.53 (0.01–2.98) 1.27 (0.76–2.02)
ividuals followed for 1 year
Fig. 2 One-year cumulative TB incidence among individuals randomized to the study (actively screened; N = 1,422) versus non-randomized
(not screened; N = 2,194); individuals with active TB at baseline screening and those who left the prison during the first year were excluded
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passively between the two active screening points. En-
hanced screening for active TB, while valuable, may be in-
sufficient to effectively control TB in prisons [8]. Most
likely, multiple interventions will be necessary to reduce
TB transmission in prisons in resource-poor countries.
Emphasis on direct measures to reduce transmission, such
as reducing crowding and improving ventilation [7], or re-
ducing disease risk among recently infected inmates, may
be needed to control TB under these conditions.
There are two broad classes of proven interventions
for averting TB transmission: expedited diagnosis with
treatment of infectious cases, and preventive therapy for
LTBI. In Alaska (U.S.), for example, vigorous programs
for early diagnosis, treatment and isoniazid preventive
therapy (IPT) had rapid and dramatic effects on TB inci-
dence and transmission [18, 19]. Currently, the WHO
provides a conditional recommendation for LTBI screen-
ing and provision of isoniazid preventive therapy (IPT)
in prisons in high and upper middle-income countries
[20], but the Brazilian MoH does not recommend treat-
ing inmates with a positive TST. In contrast, treatment
is recommended and has been shown to be effective in
controlling the disease in other high-risk populations,
such as indigenous groups [21]. Screening for TB at the
entry and annually, with provision of IPT for infected in-
dividuals, has been effective at reducing TB incidence in
the United States [22], but there are few published data
on the use of IPT in penal institutions in resource-poorcountries. Our finding of low LTBI prevalence at time of
prison admission and a high rate of TST conversion after
one year suggests that annual TST screening and treat-
ment of LTBI could potentially be an effective interven-
tion in this setting [23].
Although two previous cross-sectional studies have
shown that drug use was associated with active TB in
prisoners populations [24, 25], this is the first cohort
study designed to identify individual risk factors associ-
ated with active TB inside the prisons. Drug use over the
last year (AHR 3.22; 95 % CI 1.05–9.89) was associated
with active TB and drug abuse program need to imple-
ment to reduce the incidence of active TB in prisons.
Urrego et al. documented overcrowding and inad-
equate ventilation in 3 prisons included in this study [7].
In a recent study in prisons in Chile, overcrowding was
identified as a key determinant of LTBI among contacts
of active TB cases [14]. In our study, female prisons were
at 148 % (669/451) capacity, while male prisons were at
265 % (6,552/2,469) capacity (Table 2). The higher TST
conversion rates and active TB incidence in male prisons
compared with female prisoners may be in part due to
greater overcrowding in the former.
Our findings are subject to several limitations. We
used the TST conversion to assess tuberculosis infec-
tions, which has imperfect sensitivity and specificity, but
is the primary modality of latent tuberculosis infection
testing in Brazil. To test for active tuberculosis, we per-
formed smear and culture on two sputum specimens.
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could enhance screening sensitivity and could potentially
decrease TB transmission and incidence. While recom-
mended by Brazilian guidelines, screening for TB upon
entry into prisons is not routinely performed. TB inci-
dence in the general population of this state is <40 per
100,000, and we have previously found LTBI prevalence
of <10 % at entry to prisons [8], suggesting entry screen-
ing may have low yield [26].
At the individual level, we found no impact of screen-
ing on subsequent TB diagnosis rates. We enrolled only
half (3,380/7,221) of the total prisoner population, and
transmission from the unscreened group may have lim-
ited any population-level transmission benefits of
screening. Achieving higher screening coverage and
screening more frequently would likely have a greater
impact on subsequent TB incidence in both the screened
and non-screened population. A caveat is that the me-
dian duration of incarceration is under 2 years in this
population, meaning that the inmate population turns
over quickly between annual screenings, potentially
diminishing the impact of this intervention. An add-
itional consequence of the high turnover rates are that
loss to follow-up in prospective cohorts of prisoners are
high, as was the case in this study; since we randomly
selected inmates for screening, this was unlikely to bias
the study findings. We did not collect clinical or demo-
graphic data on the inmates who were not enrolled in
the screening group; as we randomly selected individuals
for recruitment and participation rates were high, the
risk for selection bias was low. Additionally, our findings
were from the “closed” system, where prisoners are in-
carcerated continuously, and further work is needed to
characterize risks in the “open” system, a transitional en-
vironment where prisoners are only housed at night.
Conclusions
In a network of 12 prisons in central western Brazil, TB in-
fection and disease rates were extraordinarily high. More
aggressive interventions—including more frequent screen-
ing and use of preventive therapy—may be required to re-
duce the burden of TB in this high transmission setting.
Moreover, the high TB rates found in these prisons not
only represent an institutional public health crisis, but also
a threat to the control of TB in the broader population, as
supported by molecular evidence of spillover in this com-
munity [15]. The high rate of incarceration and movement
combined with extraordinary infection rates, indicate that
prisons can be important reservoirs of TB transmission to
the general population. Urgent interventions are needed to
address the unimpeded spread of TB in Brazil’s prisons.
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